Author: Fleming, Heather E ; Walesky, Chad ; Evans, Helen ; Shan, Jing ; Schepers, Arnout G ; Goessling, Wolfram ; Huang, Ada ; Bhatia, Sangeeta N ; Cox, Andrew G

The utility of in vitro human disease models is mainly dependent on the availability and functional maturity of tissue-specific cell types. We have previously screened for and identified small molecules that can enhance hepatocyte function in vitro. Here, we characterize the functional effects of one of the hits, FH1, on primary human hepatocytes in vitro, and also in vivo on primary hepatocytes in a zebrafish model. Furthermore, we conducted an analogue screen to establish the structure-activity relationship of FH1. We performed affinity-purification proteomics that identified NQO2 to be a potential binding target for this small molecule, revealing a possible link between inflammatory signaling and hepatocellular function in zebrafish and human hepatocyte model systems.

01 Sep 2020·Bulletin of Environmental Contamination and ToxicologyQ4 · ENVIRONMENTAL SCIENCE & ECOLOGY

Biodegradation of Atrazine by Mixed Bacteria of Klebsiella variicola Strain FH-1 and Arthrobacter sp. NJ-1

Q4 · ENVIRONMENTAL SCIENCE & ECOLOGY

Article

Author: Zhang, Jinpeng ; Zhao, Xiaofeng ; Gao, Ning ; Zhang, Hao ; Ma, Xiulan ; Pan, Zequn

The purpose of this study is to enhance the biodegradability of atrazine with FH-1 and NJ-1 alone by selecting the mixing ratio, optimizing the culture medium and conditions. The results showed that FH-1 and NJ-1 have the best biodegradation effect on atrazine being mixed in a volume ratio of 3:2. In a single factor experiment, sucrose and NH₄Cl provided carbon and nitrogen sources for the mixed bacteria. Subsequently, composition of fermentation medium was further optimized using Box-Behnken design of response surface methodology. Based on the results, growth of mixed bacteria and biodegradation of atrazine performed best effects with a biodegradation rate of 85.6% when sucrose and NH₄Cl amounts were 35.30 g/L and 10.28 g/L. The optimal medium condition was 10% inoculum of mixed bacteria, with initial atrazine concentration of 50 mg/L, neutral or weakly alkaline pH value, 30°C. The biodegradation rate reached 97.4%, 11.8% higher than the unoptimized condition.

01 Jan 1988·Chemical and Pharmaceutical BulletinQ4 · MEDICINE

Estimation of the rates of available fraction for some 4-substituted acetophenone derivatives in the rat: Reversible drug-metabolite pharmacokinetics.

Q4 · MEDICINE

Article

Author: ASADA, SHOZO ; OTAWA, TOMOKO ; NAKAE, HIROKO ; NAGAMINE, SACHIKO

4-Acetamidoacetophenone, 4-acetylbenzenesulfonamide, and acetohexamide and the resp. reduced compounds, 4-substituted α-hydroxyethylphenyl derivatives, are in a reversible drug-metabolite relationship in rats.The pharmacokinetic profiles of these agents were studied after intraportal (pv) administration in comparison with those after i.v. administration using an interconversion model.Fundamental clearances, CL₁₀, CL₁₂, CL₂₀ and CL₂₁, were calculated using four AUC (area under the plasma concentration-time curve) values obtained after i.v. administration of the drug and preformed metabolite.The hepatic available fraction of parent drug, F_H1 and sequential hepatic available fraction of its metabolite, F_H2, also were estimated

100 Deals associated with Fluoro L-HIPPO-1

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
HIV Infections	Preclinical	Japan	Kumamoto University	12 Oct 2022
HIV Infections	Preclinical	Japan	Science Farm Co. Ltd.	12 Oct 2022
HIV Infections	Preclinical	Turkey	KOC University	12 Oct 2022

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

Fluoro L-HIPPO-1

Overview

Basic Info

Related

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation